BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Peptide Therapy Prescription in 2025: Your Safe Guide